Suspension Compositions Of Cyclosporin A For Subconjunctival And Periocular Injection

Patent No. EP3169308 (titled "Suspension Compositions Of Cyclosporin A For Subconjunctival And Periocular Injection") was filed by Allergan on Jul 20, 2015. The application was issued on Jan 27, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GILL JENNINGS & EVERYOct 27, 2021GILL JENNINGS & EVERY

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3169308

ALLERGAN
Application Number
EP15744833A
Filing Date
Jul 20, 2015
Status
Revoked
Jul 8, 2022
Publication Date
Jan 27, 2021